About Sunflower Pharmaceutical Group Company

The company aims to “ensure the safety of Chinese children's medication use and care for the healthy growth of Chinese children. With the mission of “making good medicine for ordinary people and bringing a healthy and beautiful life to hundreds of millions of families,” it is a well-known pharmaceutical company with branded OTC products as the core, covering the entire R&D, production and sales industry chain. The company is a large brand pharmaceutical group enterprise which is led by the production of proprietary Chinese medicines, has “chemical drugs, biopharmaceuticals” and “health and health products” as its two wings, and integrates R&D, manufacturing and marketing of pharmaceuticals and health products. The main products include: pediatric pulmonary fever, cough and asthma oral liquid/granules, pediatric Chai Gui antipyretic granules, dendrobium granules, sunflower oil, pediatric aminophenolamine granules/tablets, liver protection tablets, Weikangling capsules/granules, etc. Corporate honors: “China's Top 100 Traditional Chinese Medicine Companies” ranked 15th, Sunflower Wei Kangling was selected - 2024 Meath Club (China Pharmaceutical and Health Industry Symbiosis Conference) - “2024 China Pharmaceutical Brand List” retail terminal winning brand; Sunflower Liver Protection won the -2024 Xiding Conference (Health Products Trade Conference) - “2023-2024 China Pharmaceutical Retail Market Potential Brand”, won the “Leading Brand in the Pharmaceutical Industry” award at the 18th China Consumer Economy High-Level Forum - “Pharmaceutical Industry Leading Brand” award; won the “Pharmaceutical Industry Leading Brand” award Strong Press conference - “2024 China's Top 500 Innovative Brands” list; Sunflower Pharmaceutical won the 2024 MiSi Conference (China Pharmaceutical and Health Industry Symbiosis Conference) - “2023 China Pharmaceutical Industry Top 100 Series List” - “Top 100 Chinese Medicine Companies Ranking” - ranked 13th.